Seroatlas · Human Serome Atlas

GPCPD1

Glycerophosphocholine phosphodiesterase GPCPD1

Also known as: GDE5, GDPD6, GPCP1_HUMAN, KIAA1434

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9NPB8
Gene
GPCPD1
Ensembl
ENSG00000125772
Chromosome
20
Canonical length
672 aa
Protein class
Enzymes, Metabolic proteins, Predicted intracellular proteins
Subcellular location
Nucleoplasm

OverviewNCBI Gene

Predicted to enable glycerophosphocholine phosphodiesterase activity. Predicted to be involved in glycerophospholipid catabolic process. Predicted to act upstream of or within skeletal muscle tissue development. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Jul 2025]

Canonical amino-acid sequenceUniProt

672 residues, UniProt reviewed canonical sequence.

>Q9NPB8|GPCPD1
     1  MTPSQVAFEI RGTLLPGEVF AICGSCDALG NWNPQNAVAL LPENDTGESM LWKATIVLSR
    61  GVSVQYRYFK GYFLEPKTIG GPCQVIVHKW ETHLQPRSIT PLESEIIIDD GQFGIHNGVE
   121  TLDSGWLTCQ TEIRLRLHYS EKPPVSITKK KLKKSRFRVK LTLEGLEEDD DDRVSPTVLH
   181  KMSNSLEISL ISDNEFKCRH SQPECGYGLQ PDRWTEYSIQ TMEPDNLELI FDFFEEDLSE
   241  HVVQGDALPG HVGTACLLSS TIAESGKSAG ILTLPIMSRN SRKTIGKVRV DYIIIKPLPG
   301  YSCDMKSSFS KYWKPRIPLD VGHRGAGNST TTAQLAKVQE NTIASLRNAA SHGAAFVEFD
   361  VHLSKDFVPV VYHDLTCCLT MKKKFDADPV ELFEIPVKEL TFDQLQLLKL THVTALKSKD
   421  RKESVVQEEN SFSENQPFPS LKMVLESLPE DVGFNIEIKW ICQQRDGMWD GNLSTYFDMN
   481  LFLDIILKTV LENSGKRRIV FSSFDADICT MVRQKQNKYP ILFLTQGKSE IYPELMDLRS
   541  RTTPIAMSFA QFENLLGINV HTEDLLRNPS YIQEAKAKGL VIFCWGDDTN DPENRRKLKE
   601  LGVNGLIYDR IYDWMPEQPN IFQVEQLERL KQELPELKSC LCPTVSRFVP SSLCGESDIH
   661  VDANGIDNVE NA

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against GPCPD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.26
Highest tissue expression
71 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 71 nTPM
  • cerebellum: 33 nTPM
  • spleen: 31 nTPM
  • lung: 27 nTPM
  • salivary gland: 25 nTPM
  • ovary: 23 nTPM

Single-cell type

  • neutrophils: 1,542 nCPM
  • monocytes: 1,141 nCPM
  • salivary acinar cells: 512 nCPM
  • monocyte progenitors: 494 nCPM
  • neutrophil progenitors: 424 nCPM
  • endometrial glandular cells: 392 nCPM

Immune cell

  • neutrophil: 16 nTPM
  • eosinophil: 9.2 nTPM
  • classical monocyte: 7.4 nTPM
  • non-classical monocyte: 5.8 nTPM
  • intermediate monocyte: 5.5 nTPM
  • myeloid DC: 4.5 nTPM

Brain region

  • pons: 26 nTPM
  • cerebellum: 25 nTPM
  • cerebral cortex: 24 nTPM
  • thalamus: 21 nTPM
  • hypothalamus: 20 nTPM
  • spinal cord: 20 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about GPCPD1.

Disease | ImmuneIEDB

Conditions an epitope on GPCPD1 was assayed in.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.42
gnomAD pLI
0.2
gnomAD missense Z
2.05
DepMap mean gene effect
0
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of GPCPD1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads GPCPD1 as an antibody target. Whether an autoantibody or antibody against GPCPD1 could matter depends on whether native GPCPD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

GPCPD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label GPCPD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/GPCPD1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...